Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gil Melmed

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
The American Journal of Gastroenterology|December 18, 2013
Development of an online library of patient-reported outcome measures in gastroenterology: the GI-PRO databasePuja Khanna, Nikhil Agarwal, Dinesh Khanna, et al.
Crohn'S & Colitis 360|April 22, 2025
Efficacy and Safety of Mirikizumab in the Treatment of Moderately to Severely Active Ulcerative Colitis Regardless of Baseline Modified Mayo Score: Results From the Phase 3 LUCENT TrialsBincy Abraham, Jianmin Wu, Séverine Vermeire, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 30, 2020
Development and Pilot Testing of the Inflammatory Bowel Disease Nutrition Care PathwayCaroline Hwang, Kelly Issokson, Catherine Giguere-Rich, et al.
Inflammatory Bowel Diseases|December 23, 2009
Combination of innate and adaptive immune alterations increased the likelihood of fibrostenosis in Crohn's diseaseAndrew Ippoliti, Shane Devlin, Ling Mei, et al.
Genome Medicine|August 15, 2022
Crohn's disease in endoscopic remission, obesity, and cases of high genetic risk demonstrates overlapping shifts in the colonic mucosal-luminal interface microbiomeJonathan P Jacobs, Maryam Goudarzi, Venu Lagishetty, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 7, 2022
Comparative Safety and Effectiveness of Biologic Therapy for Crohn's Disease: A CA-IBD Cohort StudySiddharth Singh, Jihoon Kim, Jiyu Luo, et al.
Human Molecular Genetics|June 24, 2010
Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's diseaseDermot P B McGovern, Michelle R Jones, Kent D Taylor, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 1, 2022
Effectiveness and Safety of Biologic Therapy in Hispanic Vs Non-Hispanic Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort StudyNghia H Nguyen, Jiyu Luo, Paulina Paul, et al.
Gastroenterology|March 15, 2024
Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel DiseaseMichelle Khrom, Millie Long, Shishir Dube, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
The American Journal of Gastroenterology|December 18, 2013
Development of an online library of patient-reported outcome measures in gastroenterology: the GI-PRO databasePuja Khanna, Nikhil Agarwal, Dinesh Khanna, et al.
Crohn'S & Colitis 360|April 22, 2025
Efficacy and Safety of Mirikizumab in the Treatment of Moderately to Severely Active Ulcerative Colitis Regardless of Baseline Modified Mayo Score: Results From the Phase 3 LUCENT TrialsBincy Abraham, Jianmin Wu, Séverine Vermeire, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 30, 2020
Development and Pilot Testing of the Inflammatory Bowel Disease Nutrition Care PathwayCaroline Hwang, Kelly Issokson, Catherine Giguere-Rich, et al.
Inflammatory Bowel Diseases|December 23, 2009
Combination of innate and adaptive immune alterations increased the likelihood of fibrostenosis in Crohn's diseaseAndrew Ippoliti, Shane Devlin, Ling Mei, et al.
Genome Medicine|August 15, 2022
Crohn's disease in endoscopic remission, obesity, and cases of high genetic risk demonstrates overlapping shifts in the colonic mucosal-luminal interface microbiomeJonathan P Jacobs, Maryam Goudarzi, Venu Lagishetty, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 7, 2022
Comparative Safety and Effectiveness of Biologic Therapy for Crohn's Disease: A CA-IBD Cohort StudySiddharth Singh, Jihoon Kim, Jiyu Luo, et al.
Human Molecular Genetics|June 24, 2010
Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's diseaseDermot P B McGovern, Michelle R Jones, Kent D Taylor, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 1, 2022
Effectiveness and Safety of Biologic Therapy in Hispanic Vs Non-Hispanic Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort StudyNghia H Nguyen, Jiyu Luo, Paulina Paul, et al.
Gastroenterology|March 15, 2024
Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel DiseaseMichelle Khrom, Millie Long, Shishir Dube, et al.
Pageof 3